CLINICAL TRIALS PROFILE FOR CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
✉ Email this page to a colleague
All Clinical Trials for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT02582177 ↗ | Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis | Completed | Ache Laboratorios Farmaceuticos S.A. | Phase 3 | 2019-06-11 | To evaluate the no-inferiority of the ketoconazole20mg/g and betamethasone dipropionate 0.64 mg/g association (Candicort®) cream versus clotrimazole 10mg and dexamethasone acetate 0.443 mg/g association (Baycuten N®) cream, general relief of signs and symptoms (erythema, maceration, peeling, blistering / papules / pustules, itching and burning / stinging) 06 (± 1) days after onset treatment. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Condition Name
Clinical Trial Locations for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Clinical Trial Progress for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Clinical Trial Phase
Clinical Trial Sponsors for CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE
Sponsor Name